PO-160 Investigation of ubiquitin-ligase HUWE1 in the modulation of RAS pathway in leukaemia models

IntroductionThe RAS/RAF/MEK/ERK pathway is frequently hyperactivated in several tumours. In leukaemia, this activation can arise, among other mechanisms, from point mutations in the RAS genes, which are important in acute lymphoid leukaemia (ALL) and acute myeloid leukaemia (AML), or from chromosomal translocations such as the BCR-ABL gene, which is a driver mutation in chronic myeloid leukaemia (CML) and some cases of ALL. The hyperactivation of this pathway stimulates cell proliferation and, consequently, the production of reactive oxygen species (ROS), which is one of the main mechanisms involved with induction of cellular senescence in tumours. Thus, tumour cells that harbour the mutated RAS gene are critically dependent on feedback mechanisms to regulate pathway activation. Jang et al. demonstrated that the ubiquitin-ligase HUWE1 acts on a negative feedback mechanism that controls the activation of ERK1/2. Although widely studied in the context of tumorigenesis, the role of this molecule in events related to leukemogenesis has not yet been described.Material and methodsIn this study, leukaemia cell lines and human hematopoietic stem and progenitors cells (HSPCs) with KRASG12V mutation were transduced with miR-E lentiviral particles for HUWE1 knockdown. Cell proliferation, apoptosis, ROS production and analysis of gene and protein expression were performed in cell lines; cumulative growth analysis, cobblestones area formations, clonogenic capacity and differentiation profile analysis were performed in HSPCs.Results and discussionsIn cell lines, it was observed that HUWE1 knockdown reduced the proliferative capacity of Nalm-6, K562 and THP-1, but not of HL-60. Besides that, it caused a reduction in ROS production (p